In the PPI network,we identified ten hub genes, namely, STAT3, TP53, MAPK3, AKT1, JUN, EGFR, MYC, VEGFA, EGF, and CTNNB1, which may be the targets of HS in the treatment of CRC. This evidence concerns the gene TP53 and colorectal carcinoma.